Literature DB >> 30728267

Conserved Gammaherpesvirus Protein Kinase Selectively Promotes Irrelevant B Cell Responses.

Eric J Darrah1, Christopher N Jondle1, Kaitlin E Johnson1, Gang Xin2, Philip T Lange1, Weiguo Cui2, Horatiu Olteanu3,4, Vera L Tarakanova5,3.   

Abstract

Gammaherpesviruses are ubiquitous pathogens that are associated with B cell lymphomas. In the early stages of chronic infection, these viruses infect naive B cells and subsequently usurp the B cell differentiation process through the germinal center response to ensure latent infection of long-lived memory B cells. A unique feature of early gammaherpesvirus chronic infection is a robust differentiation of irrelevant, virus-nonspecific B cells with reactivities against self-antigens and antigens of other species. In contrast, protective, virus-specific humoral responses do not reach peak levels until a much later time. While several host factors are known to either promote or selectively restrict gammaherpesvirus-driven germinal center response, viral mechanisms that contribute to the irrelevant B cell response have not been defined. In this report we show that the expression and the enzymatic activity of the gammaherpesvirus-encoded conserved protein kinase selectively facilitates the irrelevant, but not virus-specific, B cell responses. Further, we show that lack of interleukin-1 (IL-1) receptor attenuates gammaherpesvirus-driven B cell differentiation and viral reactivation. Because germinal center B cells are thought to be the target of malignant transformation during gammaherpesvirus-driven lymphomagenesis, identification of host and viral factors that promote germinal center responses during gammaherpesvirus infection may offer an insight into the mechanism of gammaherpesvirus pathogenesis.IMPORTANCE Gammaherpesviruses are ubiquitous cancer-associated pathogens that usurp the B cell differentiation process to establish life-long latent infection in memory B cells. A unique feature of early gammaherpesvirus infection is the robust increase in differentiation of B cells that are not specific for viral antigens and instead encode antibodies that react with self-antigens and antigens of other species. Viral mechanisms that are involved in driving such irrelevant B cell differentiation are not known. Here, we show that gammaherpesvirus-encoded conserved protein kinase and host IL-1 signaling promote irrelevant B cell responses and gammaherpesvirus-driven germinal center responses, with the latter thought to be the target of viral transformation.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  B cell responses; IL-1; gammaherpesvirus; germinal center; orf36; protein kinase

Mesh:

Substances:

Year:  2019        PMID: 30728267      PMCID: PMC6450124          DOI: 10.1128/JVI.01760-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro.

Authors:  M R Chen; S J Chang; H Huang; J Y Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein.

Authors:  Christopher M Collins; Jeremy M Boss; Samuel H Speck
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

3.  Maribavir use in practice for cytomegalovirus infection in French transplantation centers.

Authors:  S Alain; M Revest; D Veyer; M Essig; J P Rerolles; W Rawlinson; C Mengelle; A Huynh; N Kamar; I Garrigue; H Kaminski; C Segard; C Presne; M C Mazeron; V Avettant-Fenoël; M Lecuit; O Lortholary; A Coaquette; S Hantz; M Leruez-Ville; M-C Ploy
Journal:  Transplant Proc       Date:  2013-05       Impact factor: 1.066

Review 4.  Gammaherpesviruses and lymphoproliferative disorders.

Authors:  Ethel Cesarman
Journal:  Annu Rev Pathol       Date:  2013-10-09       Impact factor: 23.472

5.  Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice.

Authors:  Vera L Tarakanova; Felipe Suarez; Scott A Tibbetts; Meagan A Jacoby; Karen E Weck; Jay L Hess; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Conserved gammaherpesvirus kinase and histone variant H2AX facilitate gammaherpesvirus latency in vivo.

Authors:  Vera L Tarakanova; Eleni Stanitsa; Steven M Leonardo; Tarin M Bigley; Stephen B Gauld
Journal:  Virology       Date:  2010-06-16       Impact factor: 3.616

Review 7.  Interleukin-1α.

Authors:  Peleg Rider; Yaron Carmi; Elena Voronov; Ron N Apte
Journal:  Semin Immunol       Date:  2013-11-01       Impact factor: 11.130

8.  Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.

Authors:  Kelly B McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2006-06-23       Impact factor: 6.823

9.  Ablation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo.

Authors:  Sandeep Steven Reddy; Hui-Chen Chang Foreman; Thubten Ozula Sioux; Gee Ho Park; Valeria Poli; Nancy C Reich; Laurie T Krug
Journal:  mBio       Date:  2016-08-02       Impact factor: 7.867

10.  Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway.

Authors:  Andrew Getahun; Scott M Wemlinger; Pratyaydipta Rudra; Mario L Santiago; Linda F van Dyk; John C Cambier
Journal:  J Exp Med       Date:  2017-03-24       Impact factor: 14.307

View more
  9 in total

1.  B Cell-Intrinsic Expression of Interferon Regulatory Factor 1 Supports Chronic Murine Gammaherpesvirus 68 Infection.

Authors:  C N Jondle; K E Johnson; A A Uitenbroek; P A Sylvester; C Nguyen; W Cui; V L Tarakanova
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime.

Authors:  Kaitlin E Johnson; Vera L Tarakanova
Journal:  Viral Immunol       Date:  2020-01-08       Impact factor: 2.257

3.  B Cell-Intrinsic SHP1 Expression Promotes the Gammaherpesvirus-Driven Germinal Center Response and the Establishment of Chronic Infection.

Authors:  K E Johnson; P T Lange; C N Jondle; P J Volberding; U M Lorenz; W Cui; B N Dittel; V L Tarakanova
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

4.  T Cell-Intrinsic Interleukin 17 Receptor A Signaling Supports the Establishment of Chronic Murine Gammaherpesvirus 68 Infection.

Authors:  C N Jondle; V L Tarakanova
Journal:  J Virol       Date:  2022-06-27       Impact factor: 6.549

5.  Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68.

Authors:  Jean Lee; Emily Cullum; Kyle Stoltz; Niklas Bachmann; Zoe Strong; Danielle D Millick; Lisa K Denzin; Anthony Chang; Vera Tarakanova; Alexander V Chervonsky; Tatyana Golovkina
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.426

Review 6.  Dangerous Liaisons: Gammaherpesvirus Subversion of the Immunoglobulin Repertoire.

Authors:  Monika A Zelazowska; Kevin McBride; Laurie T Krug
Journal:  Viruses       Date:  2020-07-23       Impact factor: 5.048

7.  Gammaherpesvirus-infected germinal center cells express a distinct immunoglobulin repertoire.

Authors:  Monika A Zelazowska; Qiwen Dong; Joshua B Plummer; Yi Zhong; Bin Liu; Laurie T Krug; Kevin M McBride
Journal:  Life Sci Alliance       Date:  2020-02-06

8.  Conquering the Host: Determinants of Pathogenesis Learned from Murine Gammaherpesvirus 68.

Authors:  Yiping Wang; Scott A Tibbetts; Laurie T Krug
Journal:  Annu Rev Virol       Date:  2021-09-29       Impact factor: 14.263

9.  Conserved Gammaherpesvirus Protein Kinase Counters the Antiviral Effects of Myeloid Cell-Specific STAT1 Expression To Promote the Establishment of Splenic B Cell Latency.

Authors:  P A Sylvester; C N Jondle; K P Stoltz; J Lanham; B N Dittel; V L Tarakanova
Journal:  J Virol       Date:  2021-08-10       Impact factor: 6.549

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.